Etoricoxib improves pain, function and quality of life: Results of a real-world effectiveness trial

International Journal of Rheumatic Diseases

Volumn 13, Issue 2, 2010, Pages 144-150

  Lin, Hsiao Yi ^a   Cheng, Tien Tsai ^b   Wang, Jyh Horng ^c   Lee, Chyou Shen ^d   Chen, Ming Han ^a   Lei, Vanessa ^e   Lac, Christina ^e   Gammaitoni, Arnold R ^e   Smugar, Steven S ^e   Chen, Wen Jer ^f  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d MACKAY MEMORIAL HOSPITAL   (Taiwan)

^e Merck Inc   (United States)

^f CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Analgesic; Etoricoxib; Osteoarthritis; Pain relief

Indexed keywords

ETORICOXIB; CYCLOOXYGENASE 2 INHIBITOR; PYRIDINE DERIVATIVE; SULFONE;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BLOOD PRESSURE; BRIEF PAIN INVENTORY; CLINICAL TRIAL; DAILY LIFE ACTIVITY; DISABILITY; DIZZINESS; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EYELID EDEMA; FACE EDEMA; FEMALE; GASTROINTESTINAL SYMPTOM; HAND EDEMA; HEADACHE; HEART PALPITATION; HUMAN; HYPERTENSION; INVESTIGATOR GLOBAL ASSESSMENT OF RESPONSE TO THERAPY; LEG EDEMA; LUNG ABSCESS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; OSTEOARTHRITIS; PAIN ASSESSMENT; PATIENT SATISFACTION; PERCEPTION; PERIPHERAL EDEMA; PERITONEUM ADHESION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; QUALITY OF LIFE; RASH; RATING SCALE; RESPIRATORY FAILURE; SCORING SYSTEM; SHORT FORM 36; SIDE EFFECT; THORAX PAIN; TREATMENT DURATION; TREATMENT RESPONSE; TREATMENT SATISFACTION QUESTIONNAIRE FOR MEDICATION; URETHRITIS; WALKING; WESTERN ONTARIO MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX; CONVALESCENCE; DRUG EFFECTS; HEALTH STATUS; JOINT CHARACTERISTICS AND FUNCTIONS; PAIN; PATHOPHYSIOLOGY; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX; TREATMENT FAILURE; TREATMENT OUTCOME;

AGED; CYCLOOXYGENASE 2 INHIBITORS; FEMALE; HEALTH STATUS; HUMANS; MALE; OSTEOARTHRITIS; PAIN; PATIENT SATISFACTION; PROSPECTIVE STUDIES; PYRIDINES; QUALITY OF LIFE; QUESTIONNAIRES; RANGE OF MOTION, ARTICULAR; RECOVERY OF FUNCTION; SEVERITY OF ILLNESS INDEX; SULFONES; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 77953767553     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2010.01468.x     Document Type: Article

References (19)

1. Leung AT, Malmstrom K, Gallacher AE. Efficacy and tolerability profile of etoricoxib in patients with osteoarthritis: a randomized, double-blind, placebo and active-comparator controlled 12-week efficacy trial. Curr Med Res Opin 2002, 18:49-58.
2. Gottesdiener K, Schnitzer T, Fisher C. Results of a randomized, dose-ranging trial of etoricoxib in patients with osteoarthritis. Rheumatology (Oxford) 2002, 41:1052-61.
3. Hunt RH, Harper S, Watson DJ. The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events. Am J Gastroenterol 2003, 98:1725-33.
4. Zacher J, Feldman D, Gerli R. A comparison of the therapeutic efficacy and tolerability of etoricoxib and diclofenac in patients with osteoarthritis. Curr Med Res Opin 2003, 19:725-36.
5. Wiesenhutter CW, Boice JA, Ko A. Evaluation of the comparative efficacy of etoricoxib and ibuprofen for treatment of patients with osteoarthritis: a randomized, double-blind, placebo-controlled trial. Mayo Clin Proc 2005, 80:470-9.
6. Bingham CO, Sebba AI, Rubin BR. Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies. Rheumatology (Oxford) 2007, 46:496-507.
7. Cannon CP, Curtis SP, FitzGerald GA. Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison. Lancet 2006, 368:1771-81.
8. Reginster JY, Malmstrom K, Mehta A. Evaluation of the efficacy and safety of etoricoxib compared with naproxen in two, 138-week randomised studies of patients with osteoarthritis. Ann Rheum Dis 2007, 66:945-51.
9. Baraf HS, Fuentealba C, Greenwald M. Gastrointestinal side effects of etoricoxib in patients with osteoarthritis: results of the Etoricoxib versus Diclofenac Sodium Gastrointestinal Tolerability and Effectiveness (EDGE) trial. J Rheumatol 2007, 34:408-20.
10. Puopolo A, Boice JA, Fidelholtz JL. A randomized placebo-controlled trial comparing the efficacy of etoricoxib 30 mg and ibuprofen 2400 mg for the treatment of patients with osteoarthritis. Osteoarthritis Cartilage 2007, 15:1348-56.
11. Croom KF, Siddiqui MA. Etoricoxib: a review of its use in the symptomatic treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute gouty arthritis. Drugs 2009, 69:1513-32.
12. Dobre D, van Veldhuisen DJ, DeJongste MJ. The contribution of observational studies to the knowledge of drug effectiveness in heart failure. Br J Clin Pharmacol 2007, 64:406-14.
13. Ioannidis JP, Haidich AB, Lau J. Any casualties in the clash of randomised and observational evidence? BMJ 2001, 322:879-80.
14. Atkinson MJ, Sinha A, Hass SL. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes 2004, 2:12.
15. Moore RA, Moore OA, Derry S, Peloso PM, Gammaitoni AR, Wang H. Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice. Ann Rheum Dis 2010, 69:374-9.
16. Chung WSJ, Chang HY, Shih YT, Wen CP. Self perceived mental health of Taiwan residents: results of 2001 national health interview survey. Taiwan J Public Health 2003, 22(6):465-73.
17. Sinnott C, Rogers MA, Lehmann D, Weinstock RS. Bodily pain, poor physical functioning, and poor glycemic control in adults with diabetes. Diabetes Care 2005, 28:1534.
18. Sutherland JE, Wesley RM, Cole PM, Nesvacil LJ, Daly ML, Gepner GJ. Differences and similarities between patient and physician perceptions of patient pain. Fam Med 1988, 20:343-6.
19. Marquie L, Raufaste E, Lauque D, Marine C, Ecoiffier M, Sorum P. Pain rating by patients and physicians: evidence of systematic pain miscalibration. Pain 2003, 102:289-96.